nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—PTK6—skin epidermis—vulva cancer	0.0349	0.0349	CbGeAlD
Dasatinib—TEC—vagina—vulva cancer	0.0124	0.0124	CbGeAlD
Dasatinib—KIT—skin epidermis—vulva cancer	0.0121	0.0121	CbGeAlD
Dasatinib—BMX—epithelium—vulva cancer	0.0121	0.0121	CbGeAlD
Dasatinib—SRMS—uterine cervix—vulva cancer	0.0115	0.0115	CbGeAlD
Dasatinib—PTK6—uterine cervix—vulva cancer	0.0113	0.0113	CbGeAlD
Dasatinib—BMX—urethra—vulva cancer	0.0111	0.0111	CbGeAlD
Dasatinib—PKMYT1—mammalian vulva—vulva cancer	0.0108	0.0108	CbGeAlD
Dasatinib—STAT5B—epithelium—vulva cancer	0.0108	0.0108	CbGeAlD
Dasatinib—STAT5B—uterine cervix—vulva cancer	0.0107	0.0107	CbGeAlD
Dasatinib—PTK6—urethra—vulva cancer	0.0104	0.0104	CbGeAlD
Dasatinib—PTK6—mammalian vulva—vulva cancer	0.00987	0.00987	CbGeAlD
Dasatinib—STAT5B—urethra—vulva cancer	0.0098	0.0098	CbGeAlD
Dasatinib—SIK3—uterine cervix—vulva cancer	0.00959	0.00959	CbGeAlD
Dasatinib—STAT5B—mammalian vulva—vulva cancer	0.00933	0.00933	CbGeAlD
Dasatinib—ZAK—uterine cervix—vulva cancer	0.00891	0.00891	CbGeAlD
Dasatinib—BMPR1B—epithelium—vulva cancer	0.00862	0.00862	CbGeAlD
Dasatinib—PKMYT1—vagina—vulva cancer	0.00835	0.00835	CbGeAlD
Dasatinib—ZAK—urethra—vulva cancer	0.00819	0.00819	CbGeAlD
Dasatinib—TEC—lymph node—vulva cancer	0.008	0.008	CbGeAlD
Dasatinib—TESK1—uterine cervix—vulva cancer	0.00788	0.00788	CbGeAlD
Dasatinib—ZAK—mammalian vulva—vulva cancer	0.0078	0.0078	CbGeAlD
Dasatinib—STK36—uterine cervix—vulva cancer	0.00775	0.00775	CbGeAlD
Dasatinib—EPHB3—uterine cervix—vulva cancer	0.00775	0.00775	CbGeAlD
Dasatinib—TXK—vagina—vulva cancer	0.00772	0.00772	CbGeAlD
Dasatinib—PTK6—vagina—vulva cancer	0.00764	0.00764	CbGeAlD
Dasatinib—LIMK2—uterine cervix—vulva cancer	0.0075	0.0075	CbGeAlD
Dasatinib—BTK—mammalian vulva—vulva cancer	0.00744	0.00744	CbGeAlD
Dasatinib—TESK1—urethra—vulva cancer	0.00724	0.00724	CbGeAlD
Dasatinib—CSK—uterine cervix—vulva cancer	0.00722	0.00722	CbGeAlD
Dasatinib—STK36—urethra—vulva cancer	0.00713	0.00713	CbGeAlD
Dasatinib—EPHB3—urethra—vulva cancer	0.00713	0.00713	CbGeAlD
Dasatinib—HCK—uterine cervix—vulva cancer	0.00713	0.00713	CbGeAlD
Dasatinib—TESK1—mammalian vulva—vulva cancer	0.00689	0.00689	CbGeAlD
Dasatinib—STK36—mammalian vulva—vulva cancer	0.00678	0.00678	CbGeAlD
Dasatinib—EPHB3—mammalian vulva—vulva cancer	0.00678	0.00678	CbGeAlD
Dasatinib—RIPK2—epithelium—vulva cancer	0.00676	0.00676	CbGeAlD
Dasatinib—RIPK2—uterine cervix—vulva cancer	0.0067	0.0067	CbGeAlD
Dasatinib—CSK—urethra—vulva cancer	0.00663	0.00663	CbGeAlD
Dasatinib—LIMK2—mammalian vulva—vulva cancer	0.00656	0.00656	CbGeAlD
Dasatinib—HCK—urethra—vulva cancer	0.00655	0.00655	CbGeAlD
Dasatinib—SIK1—uterine cervix—vulva cancer	0.00654	0.00654	CbGeAlD
Dasatinib—ERBB3—epithelium—vulva cancer	0.00647	0.00647	CbGeAlD
Dasatinib—ERBB3—uterine cervix—vulva cancer	0.00641	0.00641	CbGeAlD
Dasatinib—MAP3K2—uterine cervix—vulva cancer	0.00635	0.00635	CbGeAlD
Dasatinib—CYP1A1—skin epidermis—vulva cancer	0.00633	0.00633	CbGeAlD
Dasatinib—CSK—mammalian vulva—vulva cancer	0.00632	0.00632	CbGeAlD
Dasatinib—EPHB1—lymph node—vulva cancer	0.00628	0.00628	CbGeAlD
Dasatinib—HCK—mammalian vulva—vulva cancer	0.00623	0.00623	CbGeAlD
Dasatinib—RIPK2—urethra—vulva cancer	0.00616	0.00616	CbGeAlD
Dasatinib—ZAK—vagina—vulva cancer	0.00604	0.00604	CbGeAlD
Dasatinib—MAPK14—epithelium—vulva cancer	0.00602	0.00602	CbGeAlD
Dasatinib—SIK1—urethra—vulva cancer	0.00601	0.00601	CbGeAlD
Dasatinib—MAPK14—uterine cervix—vulva cancer	0.00597	0.00597	CbGeAlD
Dasatinib—EPHA4—urethra—vulva cancer	0.00595	0.00595	CbGeAlD
Dasatinib—LCK—uterine cervix—vulva cancer	0.00595	0.00595	CbGeAlD
Dasatinib—EPHA5—vagina—vulva cancer	0.00591	0.00591	CbGeAlD
Dasatinib—BTK—vagina—vulva cancer	0.00576	0.00576	CbGeAlD
Dasatinib—SIK1—mammalian vulva—vulva cancer	0.00572	0.00572	CbGeAlD
Dasatinib—EPHB4—epithelium—vulva cancer	0.00571	0.00571	CbGeAlD
Dasatinib—JAK2—epithelium—vulva cancer	0.00567	0.00567	CbGeAlD
Dasatinib—EPHA4—mammalian vulva—vulva cancer	0.00567	0.00567	CbGeAlD
Dasatinib—EPHB4—uterine cervix—vulva cancer	0.00566	0.00566	CbGeAlD
Dasatinib—JAK2—uterine cervix—vulva cancer	0.00562	0.00562	CbGeAlD
Dasatinib—EPHA2—epithelium—vulva cancer	0.0056	0.0056	CbGeAlD
Dasatinib—EPHA2—uterine cervix—vulva cancer	0.00555	0.00555	CbGeAlD
Dasatinib—FYN—uterine cervix—vulva cancer	0.00554	0.00554	CbGeAlD
Dasatinib—FGR—urethra—vulva cancer	0.00547	0.00547	CbGeAlD
Dasatinib—LCK—urethra—vulva cancer	0.00547	0.00547	CbGeAlD
Dasatinib—MAP4K5—uterine cervix—vulva cancer	0.00542	0.00542	CbGeAlD
Dasatinib—MAP3K3—uterine cervix—vulva cancer	0.00542	0.00542	CbGeAlD
Dasatinib—TESK1—vagina—vulva cancer	0.00534	0.00534	CbGeAlD
Dasatinib—BMX—lymph node—vulva cancer	0.00527	0.00527	CbGeAlD
Dasatinib—STK36—vagina—vulva cancer	0.00525	0.00525	CbGeAlD
Dasatinib—EPHB3—vagina—vulva cancer	0.00525	0.00525	CbGeAlD
Dasatinib—BLK—lymph node—vulva cancer	0.00521	0.00521	CbGeAlD
Dasatinib—FGR—mammalian vulva—vulva cancer	0.0052	0.0052	CbGeAlD
Dasatinib—LCK—mammalian vulva—vulva cancer	0.0052	0.0052	CbGeAlD
Dasatinib—EPHB4—urethra—vulva cancer	0.0052	0.0052	CbGeAlD
Dasatinib—EPHB6—uterine cervix—vulva cancer	0.00518	0.00518	CbGeAlD
Dasatinib—JAK2—urethra—vulva cancer	0.00517	0.00517	CbGeAlD
Dasatinib—EPHA2—urethra—vulva cancer	0.0051	0.0051	CbGeAlD
Dasatinib—FYN—urethra—vulva cancer	0.00509	0.00509	CbGeAlD
Dasatinib—LIMK2—vagina—vulva cancer	0.00508	0.00508	CbGeAlD
Dasatinib—FMO3—mammalian vulva—vulva cancer	0.00503	0.00503	CbGeAlD
Dasatinib—YES1—uterine cervix—vulva cancer	0.005	0.005	CbGeAlD
Dasatinib—TXK—lymph node—vulva cancer	0.00499	0.00499	CbGeAlD
Dasatinib—MAP3K3—urethra—vulva cancer	0.00498	0.00498	CbGeAlD
Dasatinib—MAP4K5—urethra—vulva cancer	0.00498	0.00498	CbGeAlD
Dasatinib—EPHB4—mammalian vulva—vulva cancer	0.00495	0.00495	CbGeAlD
Dasatinib—STK35—vagina—vulva cancer	0.00492	0.00492	CbGeAlD
Dasatinib—JAK2—mammalian vulva—vulva cancer	0.00492	0.00492	CbGeAlD
Dasatinib—CSK—vagina—vulva cancer	0.00489	0.00489	CbGeAlD
Dasatinib—EPHA2—mammalian vulva—vulva cancer	0.00486	0.00486	CbGeAlD
Dasatinib—SRC—epithelium—vulva cancer	0.00485	0.00485	CbGeAlD
Dasatinib—FYN—mammalian vulva—vulva cancer	0.00485	0.00485	CbGeAlD
Dasatinib—HCK—vagina—vulva cancer	0.00483	0.00483	CbGeAlD
Dasatinib—SRC—uterine cervix—vulva cancer	0.00481	0.00481	CbGeAlD
Dasatinib—ABL2—vagina—vulva cancer	0.0048	0.0048	CbGeAlD
Dasatinib—EPHB6—urethra—vulva cancer	0.00476	0.00476	CbGeAlD
Dasatinib—MAP3K3—mammalian vulva—vulva cancer	0.00474	0.00474	CbGeAlD
Dasatinib—MAP4K5—mammalian vulva—vulva cancer	0.00474	0.00474	CbGeAlD
Dasatinib—STAT5B—lymph node—vulva cancer	0.00467	0.00467	CbGeAlD
Dasatinib—YES1—urethra—vulva cancer	0.0046	0.0046	CbGeAlD
Dasatinib—RIPK2—vagina—vulva cancer	0.00454	0.00454	CbGeAlD
Dasatinib—EPHB6—mammalian vulva—vulva cancer	0.00453	0.00453	CbGeAlD
Dasatinib—MAP2K5—uterine cervix—vulva cancer	0.00443	0.00443	CbGeAlD
Dasatinib—EPHA4—vagina—vulva cancer	0.00439	0.00439	CbGeAlD
Dasatinib—YES1—mammalian vulva—vulva cancer	0.00438	0.00438	CbGeAlD
Dasatinib—CSF1R—uterine cervix—vulva cancer	0.00432	0.00432	CbGeAlD
Dasatinib—EPHA3—lymph node—vulva cancer	0.00432	0.00432	CbGeAlD
Dasatinib—SIK3—lymph node—vulva cancer	0.0042	0.0042	CbGeAlD
Dasatinib—MAP2K5—urethra—vulva cancer	0.00407	0.00407	CbGeAlD
Dasatinib—MAPK14—vagina—vulva cancer	0.00405	0.00405	CbGeAlD
Dasatinib—FGR—vagina—vulva cancer	0.00403	0.00403	CbGeAlD
Dasatinib—LCK—vagina—vulva cancer	0.00403	0.00403	CbGeAlD
Dasatinib—CSF1R—urethra—vulva cancer	0.00397	0.00397	CbGeAlD
Dasatinib—KIT—epithelium—vulva cancer	0.00396	0.00396	CbGeAlD
Dasatinib—KIT—uterine cervix—vulva cancer	0.00392	0.00392	CbGeAlD
Dasatinib—ZAK—lymph node—vulva cancer	0.00391	0.00391	CbGeAlD
Dasatinib—FMO3—vagina—vulva cancer	0.00389	0.00389	CbGeAlD
Dasatinib—MAP2K5—mammalian vulva—vulva cancer	0.00387	0.00387	CbGeAlD
Dasatinib—PDGFRB—epithelium—vulva cancer	0.00387	0.00387	CbGeAlD
Dasatinib—EPHB4—vagina—vulva cancer	0.00384	0.00384	CbGeAlD
Dasatinib—PDGFRB—uterine cervix—vulva cancer	0.00383	0.00383	CbGeAlD
Dasatinib—JAK2—vagina—vulva cancer	0.00381	0.00381	CbGeAlD
Dasatinib—CSF1R—mammalian vulva—vulva cancer	0.00378	0.00378	CbGeAlD
Dasatinib—EPHA2—vagina—vulva cancer	0.00376	0.00376	CbGeAlD
Dasatinib—FYN—vagina—vulva cancer	0.00376	0.00376	CbGeAlD
Dasatinib—BMPR1B—lymph node—vulva cancer	0.00375	0.00375	CbGeAlD
Dasatinib—BTK—lymph node—vulva cancer	0.00373	0.00373	CbGeAlD
Dasatinib—TNK2—lymph node—vulva cancer	0.00367	0.00367	CbGeAlD
Dasatinib—MAP4K5—vagina—vulva cancer	0.00367	0.00367	CbGeAlD
Dasatinib—MAP3K3—vagina—vulva cancer	0.00367	0.00367	CbGeAlD
Dasatinib—KIT—urethra—vulva cancer	0.00361	0.00361	CbGeAlD
Dasatinib—PDGFRB—urethra—vulva cancer	0.00352	0.00352	CbGeAlD
Dasatinib—EPHB6—vagina—vulva cancer	0.00351	0.00351	CbGeAlD
Dasatinib—TESK1—lymph node—vulva cancer	0.00345	0.00345	CbGeAlD
Dasatinib—KIT—mammalian vulva—vulva cancer	0.00343	0.00343	CbGeAlD
Dasatinib—ABL1—uterine cervix—vulva cancer	0.00342	0.00342	CbGeAlD
Dasatinib—STK36—lymph node—vulva cancer	0.0034	0.0034	CbGeAlD
Dasatinib—EPHB3—lymph node—vulva cancer	0.0034	0.0034	CbGeAlD
Dasatinib—YES1—vagina—vulva cancer	0.00339	0.00339	CbGeAlD
Dasatinib—PDGFRB—mammalian vulva—vulva cancer	0.00335	0.00335	CbGeAlD
Dasatinib—PDGFRA—vagina—vulva cancer	0.00333	0.00333	CbGeAlD
Dasatinib—LIMK2—lymph node—vulva cancer	0.00329	0.00329	CbGeAlD
Dasatinib—STK35—lymph node—vulva cancer	0.00318	0.00318	CbGeAlD
Dasatinib—CSK—lymph node—vulva cancer	0.00316	0.00316	CbGeAlD
Dasatinib—ABL1—urethra—vulva cancer	0.00314	0.00314	CbGeAlD
Dasatinib—HCK—lymph node—vulva cancer	0.00312	0.00312	CbGeAlD
Dasatinib—ABL2—lymph node—vulva cancer	0.0031	0.0031	CbGeAlD
Dasatinib—MAP2K5—vagina—vulva cancer	0.003	0.003	CbGeAlD
Dasatinib—ABL1—mammalian vulva—vulva cancer	0.00299	0.00299	CbGeAlD
Dasatinib—RIPK2—lymph node—vulva cancer	0.00294	0.00294	CbGeAlD
Dasatinib—CSF1R—vagina—vulva cancer	0.00293	0.00293	CbGeAlD
Dasatinib—SIK1—lymph node—vulva cancer	0.00287	0.00287	CbGeAlD
Dasatinib—EPHA4—lymph node—vulva cancer	0.00284	0.00284	CbGeAlD
Dasatinib—ERBB3—lymph node—vulva cancer	0.00281	0.00281	CbGeAlD
Dasatinib—MAP3K2—lymph node—vulva cancer	0.00278	0.00278	CbGeAlD
Dasatinib—KIT—vagina—vulva cancer	0.00266	0.00266	CbGeAlD
Dasatinib—MAPK14—lymph node—vulva cancer	0.00262	0.00262	CbGeAlD
Dasatinib—FGR—lymph node—vulva cancer	0.00261	0.00261	CbGeAlD
Dasatinib—LCK—lymph node—vulva cancer	0.00261	0.00261	CbGeAlD
Dasatinib—PDGFRB—vagina—vulva cancer	0.0026	0.0026	CbGeAlD
Dasatinib—FMO3—lymph node—vulva cancer	0.00252	0.00252	CbGeAlD
Dasatinib—EPHB4—lymph node—vulva cancer	0.00248	0.00248	CbGeAlD
Dasatinib—JAK2—lymph node—vulva cancer	0.00246	0.00246	CbGeAlD
Dasatinib—EPHA2—lymph node—vulva cancer	0.00243	0.00243	CbGeAlD
Dasatinib—FYN—lymph node—vulva cancer	0.00243	0.00243	CbGeAlD
Dasatinib—MAP4K5—lymph node—vulva cancer	0.00237	0.00237	CbGeAlD
Dasatinib—MAP3K3—lymph node—vulva cancer	0.00237	0.00237	CbGeAlD
Dasatinib—ABL1—vagina—vulva cancer	0.00231	0.00231	CbGeAlD
Dasatinib—EPHB6—lymph node—vulva cancer	0.00227	0.00227	CbGeAlD
Dasatinib—YES1—lymph node—vulva cancer	0.00219	0.00219	CbGeAlD
Dasatinib—ABCG2—uterine cervix—vulva cancer	0.00215	0.00215	CbGeAlD
Dasatinib—PDGFRA—lymph node—vulva cancer	0.00215	0.00215	CbGeAlD
Dasatinib—SRC—lymph node—vulva cancer	0.00211	0.00211	CbGeAlD
Dasatinib—CYP1A1—epithelium—vulva cancer	0.00206	0.00206	CbGeAlD
Dasatinib—CYP1A1—uterine cervix—vulva cancer	0.00204	0.00204	CbGeAlD
Dasatinib—CYP3A5—uterine cervix—vulva cancer	0.002	0.002	CbGeAlD
Dasatinib—ABCG2—urethra—vulva cancer	0.00198	0.00198	CbGeAlD
Dasatinib—MAP2K5—lymph node—vulva cancer	0.00194	0.00194	CbGeAlD
Dasatinib—CSF1R—lymph node—vulva cancer	0.00189	0.00189	CbGeAlD
Dasatinib—ABCG2—mammalian vulva—vulva cancer	0.00188	0.00188	CbGeAlD
Dasatinib—CYP1A1—urethra—vulva cancer	0.00188	0.00188	CbGeAlD
Dasatinib—CYP1A1—mammalian vulva—vulva cancer	0.00179	0.00179	CbGeAlD
Dasatinib—KIT—lymph node—vulva cancer	0.00172	0.00172	CbGeAlD
Dasatinib—PDGFRB—lymph node—vulva cancer	0.00168	0.00168	CbGeAlD
Dasatinib—ABL1—lymph node—vulva cancer	0.0015	0.0015	CbGeAlD
Dasatinib—ABCG2—vagina—vulva cancer	0.00146	0.00146	CbGeAlD
Dasatinib—CYP1A1—vagina—vulva cancer	0.00139	0.00139	CbGeAlD
Dasatinib—CYP3A5—vagina—vulva cancer	0.00135	0.00135	CbGeAlD
Dasatinib—CYP1B1—lymph node—vulva cancer	0.00127	0.00127	CbGeAlD
Dasatinib—ABCB1—epithelium—vulva cancer	0.00107	0.00107	CbGeAlD
Dasatinib—ABCB1—uterine cervix—vulva cancer	0.00106	0.00106	CbGeAlD
Dasatinib—ABCB1—urethra—vulva cancer	0.000976	0.000976	CbGeAlD
Dasatinib—ABCG2—lymph node—vulva cancer	0.000944	0.000944	CbGeAlD
Dasatinib—ABCB1—mammalian vulva—vulva cancer	0.000929	0.000929	CbGeAlD
Dasatinib—CYP1A1—lymph node—vulva cancer	0.000896	0.000896	CbGeAlD
Dasatinib—ABCB1—vagina—vulva cancer	0.00072	0.00072	CbGeAlD
Dasatinib—ABCB1—lymph node—vulva cancer	0.000466	0.000466	CbGeAlD
